1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hong Kong Pharmaceuticals and Healthcare Report Q4 2016

Hong Kong Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 95 pages

Includes 3 FREE quarterly updates


BMI View:
The demand for healthcare services in Hong Kong will be robust. With an ageing population dovetailing with lifestyle changes, chronic conditions will become increasingly prevalent in the region. This bodes well for medicine sales especially as access to healthcare is high. We expect telecare to play a more prominent role in the delivery of healthcare in Hong Kong as the authorities seek to adapt the medical system to accommodate the changing epidemiological profile.
Headline Expenditure Projections
Pharmaceuticals: HKD13.0bn (USD1.7bn) in 2015 to HKD13.9bn (USD1.8bn) in 2016; +7.1% in local currency and 6.9% US dollars terms. Forecast maintained from previous quarter. Healthcare: HKD142.7bn (USD18.4bn) in 2015 to HKD153.7bn (USD19.8bn) in 2016; +7.7% in local currency and 7.5% in US dollars terms. Slight upward revision from previous quarter.

Table Of Contents

Hong Kong Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Hong Kong 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2014-2020) 28
Industry Risk/Reward Index 29
Asia Pacific Risk/Reward Index - Q4 2016 29
Hong Kong Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Table: Processed Applications 39
Intellectual Property Issues 41
Pricing And Reimbursement Regime 42
Market Overview 44
Healthcare Sector 45
Table: Healthcare Resources (Hong Kong 2010-2015) 47
Table: Healthcare Personnel (Hong Kong 2010-2015) 47
Table: Healthcare Activity (Hong Kong 2010-2015) 48
Clinical Trials 53
Table: Top Causes Of Deaths In Hong Kong 56
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 61
Company Profile 63
Wuyi International Pharmaceutical 63
CK Life Sciences 66
GlaxoSmithKline 70
Pfizer 73
Sanofi 76
Merck and Co 79
Novartis 81
Demographic Forecast 84
Table: Population Headline Indicators (Hong Kong 1990-2025) 85
Table: Key Population Ratios (Hong Kong 1990-2025) 85
Table: Urban/Rural Population and Life Expectancy (Hong Kong 1990-2025) 86
Table: Population By Age Group (Hong Kong 1990-2025) 86
Table: Population By Age Group % (Hong Kong 1990-2025) 87
Glossary 89
Methodology 91
Pharmaceutical Expenditure Forecast Model 91
Healthcare Expenditure Forecast Model 91
Notes On Methodology 92
Risk/Reward Index Methodology 93
Index Overview 94
Table: Pharmaceutical Risk/Reward Index Indicators 94
Indicator Weightings 95

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.